Stoke Therapeutics Inc
STOK
$23.95-1.40%
End of day · as of Oct 9, 2026, 2:15 AM ET
Mkt cap
$1.88B
EV/Sales
9.76
P/E ratio
N/A
FY2025 Revenue
$184.42M
EPS (TTM)
$-3.35
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-3.73%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Stoke Therapeutics Inc (STOK) is a biotechnology company listed on NASDAQ.
Latest reported STOK revenue for 2025-12-31 was $184.4M. Net income was -$6.9M. Revenue was up 404.5% from 2024-12-31 to 2025-12-31. STOK currently screens at market cap $1.88B.
Use this STOK research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full STOK income, balance, and cash tables.
Stoke Therapeutics Inc (STOK) is a biotechnology company in the Healthcare sector.
Latest cached Stoke Therapeutics Inc (STOK) revenue for Dec 31, 2025 was $184.4M. Net income was -$6.9M. Statements: https://lician.com/financials/stok
Stoke Therapeutics Inc (STOK) market capitalization is $1.88B on the latest cached snapshot.
Stoke Therapeutics Inc (STOK) cached previous close $24.29; day range $23.65 – $24.29; volume 656,424. Session quote: https://lician.com/quote/stok
Stoke Therapeutics Inc (STOK) latest cached earnings event is "STOK earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings
The latest cached STOK filing is 8-K · Sep 25, 2026. Filings: https://lician.com/sec/stok